Oslo, Norway, March 27, 2025

Norda ASA has today acquired 3,000,000 shares in Nykode Therapeutics ASA at an average price of NOK 2.1388 per share. Christian Åbyholm is Chairman of the Board of Norda ASA and is a Member of the Board of Directors and primary insider in Nykode Therapeutics ASA. Following the transaction NORDA ASA holds 15,996,755 shares in Nykode Therapeutics ASA.  For further details, please see the attached form.

Norda ASA will together with Christian Åbyholm and the Group of companies Victoria India Fund AS and Caaby AS following the share transaction hold in total 35,857,225 shares in Nykode Therapeutics ASA, corresponding to approx. 11.0% of the total outstanding shares.


